BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Treacy O, Brown NN, Dimeski G. Biochemical evaluation of kidney disease. Transl Androl Urol 2019;8:S214-23. [PMID: 31236339 DOI: 10.21037/tau.2018.10.02] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Williams BM, Cliff CL, Lee K, Squires PE, Hills CE. The Role of the NLRP3 Inflammasome in Mediating Glomerular and Tubular Injury in Diabetic Nephropathy. Front Physiol 2022;13:907504. [PMID: 35755447 DOI: 10.3389/fphys.2022.907504] [Reference Citation Analysis]
2 Verma GS, Nirmal NK, Gunpal D, Gupta H, Yadav M, Kumar N, John PJ. Intraperitoneal exposure of iron oxide nanoparticles causes dose-dependent toxicity in Wistar rats. Toxicol Ind Health 2021;37:763-75. [PMID: 34797179 DOI: 10.1177/07482337211058668] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Mehmood HR, Khan Z, Jahangir HMS, Hussain A, Elahi A, Askari SMH. Assessment of serum biochemical derangements and associated risk factors of chronic kidney disease. Journal of Taibah University Medical Sciences 2021. [DOI: 10.1016/j.jtumed.2021.09.009] [Reference Citation Analysis]
4 An H, Hu Z, Chen Y, Cheng L, Shi J, Han L. Angiotensin II-mediated improvement of renal mitochondrial function via the AMPK/PGC-1α/NRF-2 pathway is superior to norepinephrine in a rat model of septic shock associated with acute renal injury. Ann Transl Med 2021;9:481. [PMID: 33850878 DOI: 10.21037/atm-21-621] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Gao Y, Jia J, Liu X, Guo S, Ming L. Trimester-Specific Reference Intervals of Serum Urea, Creatinine, and Uric Acid Among Healthy Pregnant Women in Zhengzhou, China. Lab Med 2021;52:267-72. [PMID: 33145592 DOI: 10.1093/labmed/lmaa088] [Reference Citation Analysis]
6 Mannon RB, Armstrong B, Stock PG, Mehta AK, Farris AB, Watson N, Morrison Y, Sarwal M, Sigdel T, Bridges N, Robien M, Newell KA, Larsen CP. Avoidance of CNI and steroids using belatacept-Results of the Clinical Trials in Organ Transplantation 16 trial. Am J Transplant 2020;20:3599-608. [PMID: 32558199 DOI: 10.1111/ajt.16152] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]